Abstract:Human islet amyloid polypeptide (hIAPP or amylin) is a causative agent in pancreatic amyloid deposits found in patients with type 2 diabetes. The aggregation of full-length hIAPP(1-37) into small oligomeric species is increasingly believed to be responsible for cell dysfunction and death. However, rat IAPP (rIAPP(1-37)), which differs from hIAPP in only six of 37 residues, loses its aggregation ability to form toxic amyloid species. Atomic details of the effect of sequence on the structure and toxicity between the amyloidogenic, toxic hIAPP peptide and the nonamyloidogenic, nontoxic rIAPP peptide remain unclear. Here, we probe sequence-induced differences in structural stability, conformational dynamics, and driving forces between different hIAPP and rIAPP polymorphic forms from monomer to pentamer using molecular dynamics simulations. Simulations show that hIAPP forms from trimer to pentamer exhibit high structural stability with well-preserved in-register parallel beta-sheet and the U-bend conformation. The hIAPP trimer appears to be a smallest minimal seed in solution. The stabilities of parallel hIAPP oligomers increase with the number of peptides. Conversely, replacement of hIAPP sequence by rIAPP sequence causes a significant loss of favorable interpeptide interactions in all rIAPP oligomers, destabilizing the C-terminal beta-sheet, turn conformation, and overall stability. A less beta-sheet-rich structure and a disturbed U-shaped topology exert a large energy penalty on the self-assemble of the rIAPP peptides into highly ordered, in-register beta-sheet-rich protofibrils and fibrils, which explains the nonamyloidogenic activity of rIAPP. Moreover, the absence of interior water within the U-turn region in the well-packed higher-order hIAPP oligomers, not in the poorly packed rIAPP oligomers, also stabilizes peptide association. This work provides atomic details of the sequence-structure relationship between the amyloidogenic hIAPP and its analogues such as the nonamyloidogenic rIAPP and some mutants, which could help in the development of novel therapeutic agents to block the formation of toxic hIAPP oligomeric species for type 2 diabetes.

The Molecular Basis of Distinct Aggregation Pathways of Islet Amyloid Polypeptide*

Stabilities and Structures of Islet Amyloid Polypeptide (IAPP22-28) Oligomers: from Dimer to 16-Mer.

Seed-Induced Heterogeneous Cross-Seeding Self-Assembly of Human and Rat Islet Polypeptides.

Comparative molecular dynamics study of human islet amyloid polypeptide (IAPP) and rat IAPP oligomers.

Residual Structure in Islet Amyloid Polypeptide Mediates Its Interactions with Soluble Insulin.

2D amyloid aggregation of human islet amyloid polypeptide at the solid-liquid interface

Structural Polymorphism of Human Islet Amyloid Polypeptide (hiapp) Oligomers Highlights the Importance of Interfacial Residue Interactions.

Structural and energetic insight into the cross-seeding amyloid assemblies of human IAPP and rat IAPP

Molecular Insights into the Oligomerization Dynamics and Conformations of Amyloidogenic and Non-Amyloidogenic Amylin from Discrete Molecular Dynamics Simulations

Dynamics of the Conformational Transitions During the Dimerization of an Intrinsically Disordered Peptide: A Case Study on the Human Islet Amyloid Polypeptide Fragment

Molecular Dynamics Simulation on the Inhibition Mechanism of Peptide-Based Inhibitor of Islet Amyloid Polypeptide (iapp) to Islet Amyloid Polypeptide (Iapp(22-28)) Oligomers

Mechanism Study on the Abnormal Accumulation and Deposition of Islet Amyloid Polypeptide by Cold-Spray Ionization Mass Spectrometry.

Adsorption and Orientation of Human Islet Amyloid Polypeptide (hIAPP) Monomer at Anionic Lipid Bilayers: Implications for Membrane-Mediated Aggregation

Common fibrillar spines of amyloid-β and human islet amyloid polypeptide revealed by microelectron diffraction and structure-based inhibitors

Islet amyloid polypeptide fibril catalyzes amyloid-β aggregation by promoting fibril nucleation rather than direct axial growth

Extended structure of rat islet amyloid polypeptide in solution.

Inhibitory Mechanism of Epigallocatechin Gallate on Fibrillation and Aggregation of Amidated Human Islet Amyloid Polypeptide.

Structure and Thermodynamics of Amylin Dimer Studied by Hamiltonian-Temperature Replica Exchange Molecular Dynamics Simulations

Tuning the rate of aggregation of hIAPP into amyloid using small-molecule modulators of assembly

Lipid Interaction And Membrane Perturbation Of Human Islet Amyloid Polypeptide Monomer And Dimer By Molecular Dynamics Simulations

Cross-Seeding Interaction Between Β-Amyloid and Human Islet Amyloid Polypeptide.